Innovation
2 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 105 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Investor mix
9 investors on record; lead investors include Boehringer Ingelheim Venture Fund, T1D Fund, AdBio partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 44% |
| Private equity | 1 | 11% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 3 | 33% |
